nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylscopolamine bromide—Confusional state—Calcium Acetate—osteoporosis	0.0147	0.0148	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Estropipate—osteoporosis	0.0147	0.0147	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Alendronate—osteoporosis	0.0144	0.0145	CcSEcCtD
Methylscopolamine bromide—Constipation—Calcium Acetate—osteoporosis	0.0125	0.0125	CcSEcCtD
Methylscopolamine bromide—Drowsiness—Calcitriol—osteoporosis	0.0122	0.0122	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Calcium Acetate—osteoporosis	0.012	0.0121	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Ethinyl Estradiol—osteoporosis	0.0119	0.0119	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Risedronate—osteoporosis	0.0116	0.0116	CcSEcCtD
Methylscopolamine bromide—Constipation—Ergocalciferol—osteoporosis	0.011	0.0111	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Calcium Acetate—osteoporosis	0.0107	0.0108	CcSEcCtD
Methylscopolamine bromide—Asthenia—Calcium Acetate—osteoporosis	0.0105	0.0105	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Zoledronate—osteoporosis	0.0101	0.0101	CcSEcCtD
Methylscopolamine bromide—Tension—Estropipate—osteoporosis	0.00996	0.00999	CcSEcCtD
Methylscopolamine bromide—Nervousness—Estropipate—osteoporosis	0.00985	0.00989	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Conjugated Estrogens—osteoporosis	0.00969	0.00972	CcSEcCtD
Methylscopolamine bromide—Confusional state—Etidronic acid—osteoporosis	0.00965	0.00969	CcSEcCtD
Methylscopolamine bromide—Dizziness—Calcium Acetate—osteoporosis	0.00964	0.00968	CcSEcCtD
Methylscopolamine bromide—Vomiting—Calcium Acetate—osteoporosis	0.00927	0.00931	CcSEcCtD
Methylscopolamine bromide—Asthenia—Ergocalciferol—osteoporosis	0.00924	0.00928	CcSEcCtD
Methylscopolamine bromide—Palpitations—Estropipate—osteoporosis	0.00897	0.009	CcSEcCtD
Methylscopolamine bromide—Nausea—Calcium Acetate—osteoporosis	0.00866	0.00869	CcSEcCtD
Methylscopolamine bromide—Palpitations—Ibandronate—osteoporosis	0.0086	0.00863	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Estropipate—osteoporosis	0.00828	0.00831	CcSEcCtD
Methylscopolamine bromide—Constipation—Etidronic acid—osteoporosis	0.00818	0.00822	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Ibandronate—osteoporosis	0.0081	0.00813	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Ibandronate—osteoporosis	0.00794	0.00797	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Calcitriol—osteoporosis	0.00793	0.00796	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Etidronic acid—osteoporosis	0.00789	0.00792	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Calcitriol—osteoporosis	0.00777	0.0078	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Estradiol—osteoporosis	0.00775	0.00778	CcSEcCtD
Methylscopolamine bromide—Nausea—Ergocalciferol—osteoporosis	0.00765	0.00768	CcSEcCtD
Methylscopolamine bromide—Urticaria—Etidronic acid—osteoporosis	0.0076	0.00763	CcSEcCtD
Methylscopolamine bromide—Insomnia—Estropipate—osteoporosis	0.00749	0.00752	CcSEcCtD
Methylscopolamine bromide—Tension—Pamidronate—osteoporosis	0.00748	0.00751	CcSEcCtD
Methylscopolamine bromide—Nervousness—Pamidronate—osteoporosis	0.0074	0.00743	CcSEcCtD
Methylscopolamine bromide—Somnolence—Estropipate—osteoporosis	0.00736	0.00739	CcSEcCtD
Methylscopolamine bromide—Insomnia—Raloxifene—osteoporosis	0.00725	0.00728	CcSEcCtD
Methylscopolamine bromide—Insomnia—Ibandronate—osteoporosis	0.00718	0.00721	CcSEcCtD
Methylscopolamine bromide—Constipation—Estropipate—osteoporosis	0.00708	0.00711	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Etidronic acid—osteoporosis	0.00705	0.00708	CcSEcCtD
Methylscopolamine bromide—Insomnia—Calcitriol—osteoporosis	0.00703	0.00706	CcSEcCtD
Methylscopolamine bromide—Constipation—Alendronate—osteoporosis	0.00697	0.007	CcSEcCtD
Methylscopolamine bromide—Somnolence—Calcitriol—osteoporosis	0.00691	0.00694	CcSEcCtD
Methylscopolamine bromide—Constipation—Ibandronate—osteoporosis	0.00679	0.00682	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Alendronate—osteoporosis	0.00672	0.00675	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Risedronate—osteoporosis	0.00668	0.0067	CcSEcCtD
Methylscopolamine bromide—Constipation—Calcitriol—osteoporosis	0.00665	0.00667	CcSEcCtD
Methylscopolamine bromide—Tension—Conjugated Estrogens—osteoporosis	0.00658	0.0066	CcSEcCtD
Methylscopolamine bromide—Urticaria—Estropipate—osteoporosis	0.00658	0.0066	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Zoledronate—osteoporosis	0.00656	0.00659	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Ibandronate—osteoporosis	0.00654	0.00657	CcSEcCtD
Methylscopolamine bromide—Nervousness—Conjugated Estrogens—osteoporosis	0.00651	0.00654	CcSEcCtD
Methylscopolamine bromide—Urticaria—Alendronate—osteoporosis	0.00648	0.0065	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Conjugated Estrogens—osteoporosis	0.00632	0.00634	CcSEcCtD
Methylscopolamine bromide—Urticaria—Ibandronate—osteoporosis	0.00631	0.00633	CcSEcCtD
Methylscopolamine bromide—Confusional state—Pamidronate—osteoporosis	0.00627	0.0063	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Pamidronate—osteoporosis	0.00622	0.00624	CcSEcCtD
Methylscopolamine bromide—Urticaria—Calcitriol—osteoporosis	0.00617	0.0062	CcSEcCtD
Methylscopolamine bromide—Palpitations—Zoledronate—osteoporosis	0.00615	0.00618	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Estropipate—osteoporosis	0.0061	0.00612	CcSEcCtD
Methylscopolamine bromide—Vomiting—Etidronic acid—osteoporosis	0.00609	0.00611	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Pamidronate—osteoporosis	0.00607	0.00609	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Alendronate—osteoporosis	0.00601	0.00603	CcSEcCtD
Methylscopolamine bromide—Headache—Etidronic acid—osteoporosis	0.006	0.00602	CcSEcCtD
Methylscopolamine bromide—Asthenia—Estropipate—osteoporosis	0.00594	0.00596	CcSEcCtD
Methylscopolamine bromide—Palpitations—Conjugated Estrogens—osteoporosis	0.00592	0.00595	CcSEcCtD
Methylscopolamine bromide—Insomnia—Risedronate—osteoporosis	0.00592	0.00594	CcSEcCtD
Methylscopolamine bromide—Asthenia—Alendronate—osteoporosis	0.00585	0.00587	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Ibandronate—osteoporosis	0.00585	0.00587	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Zoledronate—osteoporosis	0.0058	0.00582	CcSEcCtD
Methylscopolamine bromide—Constipation—Ethinyl Estradiol—osteoporosis	0.00574	0.00576	CcSEcCtD
Methylscopolamine bromide—Confusional state—Zoledronate—osteoporosis	0.00573	0.00575	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Calcitriol—osteoporosis	0.00573	0.00575	CcSEcCtD
Methylscopolamine bromide—Asthenia—Ibandronate—osteoporosis	0.0057	0.00572	CcSEcCtD
Methylscopolamine bromide—Nausea—Etidronic acid—osteoporosis	0.00569	0.00571	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Zoledronate—osteoporosis	0.00568	0.0057	CcSEcCtD
Methylscopolamine bromide—Insomnia—Pamidronate—osteoporosis	0.00563	0.00565	CcSEcCtD
Methylscopolamine bromide—Constipation—Risedronate—osteoporosis	0.0056	0.00562	CcSEcCtD
Methylscopolamine bromide—Asthenia—Calcitriol—osteoporosis	0.00558	0.0056	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Zoledronate—osteoporosis	0.00555	0.00557	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.00553	0.00555	CcSEcCtD
Methylscopolamine bromide—Somnolence—Pamidronate—osteoporosis	0.00553	0.00555	CcSEcCtD
Methylscopolamine bromide—Dizziness—Estropipate—osteoporosis	0.00548	0.0055	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.00547	0.00549	CcSEcCtD
Methylscopolamine bromide—Dizziness—Alendronate—osteoporosis	0.00539	0.00541	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Conjugated Estrogens—osteoporosis	0.00534	0.00536	CcSEcCtD
Methylscopolamine bromide—Urticaria—Ethinyl Estradiol—osteoporosis	0.00533	0.00535	CcSEcCtD
Methylscopolamine bromide—Constipation—Pamidronate—osteoporosis	0.00532	0.00534	CcSEcCtD
Methylscopolamine bromide—Dizziness—Raloxifene—osteoporosis	0.0053	0.00532	CcSEcCtD
Methylscopolamine bromide—Tension—Estradiol—osteoporosis	0.00526	0.00529	CcSEcCtD
Methylscopolamine bromide—Vomiting—Estropipate—osteoporosis	0.00526	0.00529	CcSEcCtD
Methylscopolamine bromide—Dizziness—Ibandronate—osteoporosis	0.00525	0.00527	CcSEcCtD
Methylscopolamine bromide—Nervousness—Estradiol—osteoporosis	0.00521	0.00523	CcSEcCtD
Methylscopolamine bromide—Urticaria—Risedronate—osteoporosis	0.0052	0.00522	CcSEcCtD
Methylscopolamine bromide—Headache—Estropipate—osteoporosis	0.00519	0.00521	CcSEcCtD
Methylscopolamine bromide—Vomiting—Alendronate—osteoporosis	0.00519	0.00521	CcSEcCtD
Methylscopolamine bromide—Insomnia—Zoledronate—osteoporosis	0.00514	0.00516	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Pamidronate—osteoporosis	0.00513	0.00515	CcSEcCtD
Methylscopolamine bromide—Headache—Alendronate—osteoporosis	0.00511	0.00513	CcSEcCtD
Methylscopolamine bromide—Vomiting—Raloxifene—osteoporosis	0.0051	0.00512	CcSEcCtD
Methylscopolamine bromide—Somnolence—Zoledronate—osteoporosis	0.00505	0.00507	CcSEcCtD
Methylscopolamine bromide—Vomiting—Ibandronate—osteoporosis	0.00505	0.00507	CcSEcCtD
Methylscopolamine bromide—Headache—Raloxifene—osteoporosis	0.00502	0.00504	CcSEcCtD
Methylscopolamine bromide—Headache—Ibandronate—osteoporosis	0.00497	0.00499	CcSEcCtD
Methylscopolamine bromide—Insomnia—Conjugated Estrogens—osteoporosis	0.00495	0.00497	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.00494	0.00496	CcSEcCtD
Methylscopolamine bromide—Vomiting—Calcitriol—osteoporosis	0.00494	0.00496	CcSEcCtD
Methylscopolamine bromide—Nausea—Estropipate—osteoporosis	0.00492	0.00494	CcSEcCtD
Methylscopolamine bromide—Headache—Calcitriol—osteoporosis	0.00487	0.00489	CcSEcCtD
Methylscopolamine bromide—Somnolence—Conjugated Estrogens—osteoporosis	0.00486	0.00488	CcSEcCtD
Methylscopolamine bromide—Constipation—Zoledronate—osteoporosis	0.00486	0.00488	CcSEcCtD
Methylscopolamine bromide—Nausea—Alendronate—osteoporosis	0.00484	0.00486	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Risedronate—osteoporosis	0.00482	0.00484	CcSEcCtD
Methylscopolamine bromide—Asthenia—Ethinyl Estradiol—osteoporosis	0.00482	0.00483	CcSEcCtD
Methylscopolamine bromide—Nausea—Raloxifene—osteoporosis	0.00476	0.00478	CcSEcCtD
Methylscopolamine bromide—Palpitations—Estradiol—osteoporosis	0.00474	0.00476	CcSEcCtD
Methylscopolamine bromide—Nausea—Ibandronate—osteoporosis	0.00472	0.00473	CcSEcCtD
Methylscopolamine bromide—Asthenia—Risedronate—osteoporosis	0.00469	0.00471	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Zoledronate—osteoporosis	0.00468	0.0047	CcSEcCtD
Methylscopolamine bromide—Constipation—Conjugated Estrogens—osteoporosis	0.00468	0.0047	CcSEcCtD
Methylscopolamine bromide—Nausea—Calcitriol—osteoporosis	0.00462	0.00463	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Pamidronate—osteoporosis	0.00458	0.0046	CcSEcCtD
Methylscopolamine bromide—Urticaria—Zoledronate—osteoporosis	0.00451	0.00453	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Estradiol—osteoporosis	0.00447	0.00448	CcSEcCtD
Methylscopolamine bromide—Asthenia—Pamidronate—osteoporosis	0.00446	0.00448	CcSEcCtD
Methylscopolamine bromide—Dizziness—Ethinyl Estradiol—osteoporosis	0.00444	0.00446	CcSEcCtD
Methylscopolamine bromide—Confusional state—Estradiol—osteoporosis	0.00442	0.00443	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Estradiol—osteoporosis	0.00438	0.0044	CcSEcCtD
Methylscopolamine bromide—Urticaria—Conjugated Estrogens—osteoporosis	0.00435	0.00436	CcSEcCtD
Methylscopolamine bromide—Dizziness—Risedronate—osteoporosis	0.00433	0.00434	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Estradiol—osteoporosis	0.00427	0.00429	CcSEcCtD
Methylscopolamine bromide—Vomiting—Ethinyl Estradiol—osteoporosis	0.00427	0.00428	CcSEcCtD
Methylscopolamine bromide—Headache—Ethinyl Estradiol—osteoporosis	0.0042	0.00422	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Zoledronate—osteoporosis	0.00419	0.0042	CcSEcCtD
Methylscopolamine bromide—Vomiting—Risedronate—osteoporosis	0.00416	0.00418	CcSEcCtD
Methylscopolamine bromide—Dizziness—Pamidronate—osteoporosis	0.00411	0.00413	CcSEcCtD
Methylscopolamine bromide—Headache—Risedronate—osteoporosis	0.0041	0.00412	CcSEcCtD
Methylscopolamine bromide—Asthenia—Zoledronate—osteoporosis	0.00408	0.00409	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.00403	0.00405	CcSEcCtD
Methylscopolamine bromide—Nausea—Ethinyl Estradiol—osteoporosis	0.00399	0.004	CcSEcCtD
Methylscopolamine bromide—Insomnia—Estradiol—osteoporosis	0.00396	0.00398	CcSEcCtD
Methylscopolamine bromide—Vomiting—Pamidronate—osteoporosis	0.00396	0.00397	CcSEcCtD
Methylscopolamine bromide—Asthenia—Conjugated Estrogens—osteoporosis	0.00393	0.00394	CcSEcCtD
Methylscopolamine bromide—Headache—Pamidronate—osteoporosis	0.0039	0.00391	CcSEcCtD
Methylscopolamine bromide—Somnolence—Estradiol—osteoporosis	0.00389	0.00391	CcSEcCtD
Methylscopolamine bromide—Nausea—Risedronate—osteoporosis	0.00389	0.0039	CcSEcCtD
Methylscopolamine bromide—Dizziness—Zoledronate—osteoporosis	0.00376	0.00377	CcSEcCtD
Methylscopolamine bromide—Constipation—Estradiol—osteoporosis	0.00374	0.00376	CcSEcCtD
Methylscopolamine bromide—Nausea—Pamidronate—osteoporosis	0.00369	0.00371	CcSEcCtD
Methylscopolamine bromide—Dizziness—Conjugated Estrogens—osteoporosis	0.00362	0.00363	CcSEcCtD
Methylscopolamine bromide—Vomiting—Zoledronate—osteoporosis	0.00361	0.00363	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Estradiol—osteoporosis	0.00361	0.00362	CcSEcCtD
Methylscopolamine bromide—Headache—Zoledronate—osteoporosis	0.00356	0.00357	CcSEcCtD
Methylscopolamine bromide—Vomiting—Conjugated Estrogens—osteoporosis	0.00348	0.00349	CcSEcCtD
Methylscopolamine bromide—Urticaria—Estradiol—osteoporosis	0.00348	0.00349	CcSEcCtD
Methylscopolamine bromide—Headache—Conjugated Estrogens—osteoporosis	0.00343	0.00344	CcSEcCtD
Methylscopolamine bromide—Nausea—Zoledronate—osteoporosis	0.00337	0.00339	CcSEcCtD
Methylscopolamine bromide—Nausea—Conjugated Estrogens—osteoporosis	0.00325	0.00326	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Estradiol—osteoporosis	0.00323	0.00324	CcSEcCtD
Methylscopolamine bromide—Asthenia—Estradiol—osteoporosis	0.00314	0.00315	CcSEcCtD
Methylscopolamine bromide—Dizziness—Estradiol—osteoporosis	0.0029	0.00291	CcSEcCtD
Methylscopolamine bromide—Vomiting—Estradiol—osteoporosis	0.00278	0.00279	CcSEcCtD
Methylscopolamine bromide—Headache—Estradiol—osteoporosis	0.00274	0.00275	CcSEcCtD
Methylscopolamine bromide—Nausea—Estradiol—osteoporosis	0.0026	0.00261	CcSEcCtD
Methylscopolamine bromide—CHRM2—G alpha (i) signalling events—ADCY5—osteoporosis	1.32e-05	0.00339	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—MGLL—osteoporosis	1.31e-05	0.00338	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—SIDS Susceptibility Pathways—IL6R—osteoporosis	1.31e-05	0.00338	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Circadian rythm related genes—LEP—osteoporosis	1.3e-05	0.00333	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—PTHLH—osteoporosis	1.29e-05	0.00332	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—PTHLH—osteoporosis	1.29e-05	0.00331	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CALCR—osteoporosis	1.28e-05	0.00328	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—PTH1R—osteoporosis	1.28e-05	0.00328	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—PTHLH—osteoporosis	1.27e-05	0.00328	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—PTH—osteoporosis	1.25e-05	0.00322	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—CNR2—osteoporosis	1.22e-05	0.00313	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—MGLL—osteoporosis	1.21e-05	0.00311	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—MGLL—osteoporosis	1.21e-05	0.0031	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—MGLL—osteoporosis	1.19e-05	0.00307	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PKM—osteoporosis	1.19e-05	0.00305	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—FDPS—osteoporosis	1.19e-05	0.00305	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—CALCA—osteoporosis	1.14e-05	0.00292	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—PTH—osteoporosis	1.14e-05	0.00292	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—CALCA—osteoporosis	1.13e-05	0.00291	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PGLS—osteoporosis	1.12e-05	0.00289	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—GPD2—osteoporosis	1.12e-05	0.00289	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—CALCA—osteoporosis	1.12e-05	0.00289	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	1.11e-05	0.00285	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—CNR2—osteoporosis	1.11e-05	0.00285	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—WNT1—osteoporosis	1.04e-05	0.00268	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—PTHLH—osteoporosis	1.04e-05	0.00266	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—osteoporosis	1.03e-05	0.00265	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—ATIC—osteoporosis	1.03e-05	0.00264	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PNP—osteoporosis	1.03e-05	0.00264	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—osteoporosis	1.03e-05	0.00264	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—MGLL—osteoporosis	1.01e-05	0.00261	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—SIDS Susceptibility Pathways—IL1B—osteoporosis	9.99e-06	0.00257	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—SOST—osteoporosis	9.94e-06	0.00256	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—SOST—osteoporosis	9.91e-06	0.00255	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—LRP5—osteoporosis	9.9e-06	0.00255	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—SOST—osteoporosis	9.81e-06	0.00252	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—G alpha (i) signalling events—POMC—osteoporosis	9.7e-06	0.00249	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—LRP6—osteoporosis	9.47e-06	0.00244	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—PTHLH—osteoporosis	9.41e-06	0.00242	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—CALCA—osteoporosis	9.12e-06	0.00235	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PTH1R—osteoporosis	8.99e-06	0.00231	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CALCR—osteoporosis	8.99e-06	0.00231	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PTH1R—osteoporosis	8.96e-06	0.0023	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CALCR—osteoporosis	8.96e-06	0.0023	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PTH1R—osteoporosis	8.88e-06	0.00228	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CALCR—osteoporosis	8.88e-06	0.00228	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—PTH—osteoporosis	8.8e-06	0.00226	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—PTH—osteoporosis	8.78e-06	0.00226	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—OXCT1—osteoporosis	8.74e-06	0.00225	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—CA2—osteoporosis	8.74e-06	0.00225	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—PTH—osteoporosis	8.69e-06	0.00223	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—CNR2—osteoporosis	8.58e-06	0.00221	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—CNR2—osteoporosis	8.55e-06	0.0022	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—MGLL—osteoporosis	8.52e-06	0.00219	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—CNR2—osteoporosis	8.47e-06	0.00218	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR ligand binding—POMC—osteoporosis	8.45e-06	0.00217	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—CALCA—osteoporosis	8.28e-06	0.00213	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—TLN1—osteoporosis	8e-06	0.00206	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—PTH—osteoporosis	8e-06	0.00206	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—PTH—osteoporosis	7.97e-06	0.00205	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—PTH—osteoporosis	7.89e-06	0.00203	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	7.81e-06	0.00201	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—CNR2—osteoporosis	7.79e-06	0.002	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	7.78e-06	0.002	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—CNR2—osteoporosis	7.77e-06	0.002	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	7.71e-06	0.00198	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—CNR2—osteoporosis	7.69e-06	0.00198	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—WNT1—osteoporosis	7.33e-06	0.00188	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—WNT1—osteoporosis	7.3e-06	0.00188	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—PTHLH—osteoporosis	7.3e-06	0.00188	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—PTHLH—osteoporosis	7.27e-06	0.00187	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—SIDS Susceptibility Pathways—TNF—osteoporosis	7.25e-06	0.00186	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—IDH2—osteoporosis	7.24e-06	0.00186	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—WNT1—osteoporosis	7.23e-06	0.00186	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—PTHLH—osteoporosis	7.2e-06	0.00185	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—MGLL—osteoporosis	7.14e-06	0.00184	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—MGLL—osteoporosis	7.12e-06	0.00183	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—MGLL—osteoporosis	7.05e-06	0.00181	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—LRP5—osteoporosis	6.97e-06	0.00179	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—LRP5—osteoporosis	6.95e-06	0.00179	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—P4HB—osteoporosis	6.9e-06	0.00177	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—LRP5—osteoporosis	6.88e-06	0.00177	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—CYP27A1—osteoporosis	6.81e-06	0.00175	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—PTH—osteoporosis	6.71e-06	0.00172	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—LRP6—osteoporosis	6.67e-06	0.00171	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—LRP6—osteoporosis	6.65e-06	0.00171	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—PTHLH—osteoporosis	6.63e-06	0.0017	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—ACP5—osteoporosis	6.62e-06	0.0017	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—PTHLH—osteoporosis	6.6e-06	0.0017	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—RAP1A—osteoporosis	6.59e-06	0.0017	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—LRP6—osteoporosis	6.58e-06	0.00169	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—PTHLH—osteoporosis	6.54e-06	0.00168	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CNR2—osteoporosis	6.54e-06	0.00168	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	6.51e-06	0.00167	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—ADCY5—osteoporosis	6.49e-06	0.00167	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—NFATC1—osteoporosis	6.43e-06	0.00165	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—CALCA—osteoporosis	6.42e-06	0.00165	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—CALCA—osteoporosis	6.4e-06	0.00165	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—DKK1—osteoporosis	6.38e-06	0.00164	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—CALCA—osteoporosis	6.34e-06	0.00163	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—TPI1—osteoporosis	6.16e-06	0.00158	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—WNT1—osteoporosis	6.15e-06	0.00158	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—FGA—osteoporosis	5.98e-06	0.00154	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—POMC—osteoporosis	5.95e-06	0.00153	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—POMC—osteoporosis	5.93e-06	0.00152	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—ADCY5—osteoporosis	5.89e-06	0.00152	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—POMC—osteoporosis	5.87e-06	0.00151	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—SIDS Susceptibility Pathways—IL6—osteoporosis	5.85e-06	0.0015	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—CALCA—osteoporosis	5.83e-06	0.0015	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—CALCA—osteoporosis	5.81e-06	0.0015	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—P4HB—osteoporosis	5.79e-06	0.00149	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—CALCA—osteoporosis	5.76e-06	0.00148	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—GAPDH—osteoporosis	5.68e-06	0.00146	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—TLN1—osteoporosis	5.63e-06	0.00145	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—TLN1—osteoporosis	5.61e-06	0.00144	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—PTHLH—osteoporosis	5.56e-06	0.00143	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—BMP2—osteoporosis	5.56e-06	0.00143	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—TLN1—osteoporosis	5.56e-06	0.00143	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—RAP1A—osteoporosis	5.53e-06	0.00142	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—FGB—osteoporosis	5.44e-06	0.0014	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—PSMA5—osteoporosis	5.25e-06	0.00135	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—PSMA2—osteoporosis	5.25e-06	0.00135	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CALCA—osteoporosis	4.89e-06	0.00126	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—P4HB—osteoporosis	4.86e-06	0.00125	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—P4HB—osteoporosis	4.84e-06	0.00124	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Circadian rythm related genes—IL6—osteoporosis	4.84e-06	0.00124	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—P4HB—osteoporosis	4.79e-06	0.00123	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—POMC—osteoporosis	4.77e-06	0.00123	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PTH—osteoporosis	4.72e-06	0.00121	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PTH—osteoporosis	4.71e-06	0.00121	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PTH—osteoporosis	4.66e-06	0.0012	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—RAP1A—osteoporosis	4.64e-06	0.00119	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—RAP1A—osteoporosis	4.63e-06	0.00119	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CNR2—osteoporosis	4.6e-06	0.00118	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CNR2—osteoporosis	4.59e-06	0.00118	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	4.58e-06	0.00118	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—RAP1A—osteoporosis	4.58e-06	0.00118	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—ADCY5—osteoporosis	4.57e-06	0.00117	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	4.57e-06	0.00117	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—ADCY5—osteoporosis	4.55e-06	0.00117	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CNR2—osteoporosis	4.54e-06	0.00117	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—NFATC1—osteoporosis	4.53e-06	0.00116	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—NFATC1—osteoporosis	4.51e-06	0.00116	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—ADCY5—osteoporosis	4.51e-06	0.00116	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—DKK1—osteoporosis	4.49e-06	0.00116	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—DKK1—osteoporosis	4.48e-06	0.00115	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—ENO1—osteoporosis	4.47e-06	0.00115	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—NFATC1—osteoporosis	4.47e-06	0.00115	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—KL—osteoporosis	4.44e-06	0.00114	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—DKK1—osteoporosis	4.43e-06	0.00114	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PSMA2—osteoporosis	4.41e-06	0.00113	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—PSMA5—osteoporosis	4.41e-06	0.00113	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—POMC—osteoporosis	4.33e-06	0.00111	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—WNT1—osteoporosis	4.33e-06	0.00111	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—WNT1—osteoporosis	4.31e-06	0.00111	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—WNT1—osteoporosis	4.27e-06	0.0011	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—IL6R—osteoporosis	4.23e-06	0.00109	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—FGA—osteoporosis	4.21e-06	0.00108	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—FGA—osteoporosis	4.2e-06	0.00108	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—FGA—osteoporosis	4.16e-06	0.00107	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—ADCY5—osteoporosis	4.15e-06	0.00107	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—ADCY5—osteoporosis	4.14e-06	0.00106	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—ADCY5—osteoporosis	4.1e-06	0.00105	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PTHLH—osteoporosis	3.91e-06	0.00101	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—BMP2—osteoporosis	3.91e-06	0.00101	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—BMP2—osteoporosis	3.9e-06	0.001	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PTHLH—osteoporosis	3.9e-06	0.001	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PTHLH—osteoporosis	3.86e-06	0.000993	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—BMP2—osteoporosis	3.86e-06	0.000993	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—FGB—osteoporosis	3.83e-06	0.000985	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—FGB—osteoporosis	3.82e-06	0.000982	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—FGB—osteoporosis	3.78e-06	0.000972	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PSMA2—osteoporosis	3.7e-06	0.000951	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PSMA5—osteoporosis	3.7e-06	0.000951	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PSMA2—osteoporosis	3.69e-06	0.000948	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PSMA5—osteoporosis	3.69e-06	0.000948	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PSMA2—osteoporosis	3.65e-06	0.000939	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PSMA5—osteoporosis	3.65e-06	0.000939	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—CYP19A1—osteoporosis	3.58e-06	0.00092	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—ADCY5—osteoporosis	3.48e-06	0.000895	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CALCA—osteoporosis	3.45e-06	0.000886	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CALCA—osteoporosis	3.43e-06	0.000883	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CALCA—osteoporosis	3.4e-06	0.000875	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—SPP1—osteoporosis	3.37e-06	0.000866	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—POMC—osteoporosis	3.36e-06	0.000864	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—POMC—osteoporosis	3.35e-06	0.000861	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—POMC—osteoporosis	3.32e-06	0.000853	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—KL—osteoporosis	3.13e-06	0.000805	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—KL—osteoporosis	3.12e-06	0.000802	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—KL—osteoporosis	3.09e-06	0.000794	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—POMC—osteoporosis	3.05e-06	0.000785	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—IRS2—osteoporosis	3.05e-06	0.000783	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—POMC—osteoporosis	3.04e-06	0.000782	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—POMC—osteoporosis	3.01e-06	0.000775	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—LEP—osteoporosis	2.98e-06	0.000766	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—IL6R—osteoporosis	2.98e-06	0.000766	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—IL6R—osteoporosis	2.97e-06	0.000763	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—IL6R—osteoporosis	2.94e-06	0.000756	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—ADCY5—osteoporosis	2.92e-06	0.000751	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—GPX1—osteoporosis	2.91e-06	0.000749	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—ESR1—osteoporosis	2.85e-06	0.000732	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—MTHFR—osteoporosis	2.69e-06	0.000691	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—IRS1—osteoporosis	2.66e-06	0.000684	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—POMC—osteoporosis	2.56e-06	0.000658	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—IL6R—osteoporosis	2.5e-06	0.000642	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—IGF1—osteoporosis	2.46e-06	0.000633	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—ADCY5—osteoporosis	2.45e-06	0.00063	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—ADCY5—osteoporosis	2.44e-06	0.000628	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—ADCY5—osteoporosis	2.42e-06	0.000622	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—SPP1—osteoporosis	2.37e-06	0.00061	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—SPP1—osteoporosis	2.36e-06	0.000608	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—SPP1—osteoporosis	2.34e-06	0.000602	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—POMC—osteoporosis	2.15e-06	0.000553	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—IRS2—osteoporosis	2.14e-06	0.000551	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—IRS2—osteoporosis	2.14e-06	0.00055	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—IRS2—osteoporosis	2.12e-06	0.000544	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—LEP—osteoporosis	2.1e-06	0.00054	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—LEP—osteoporosis	2.09e-06	0.000538	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—LEP—osteoporosis	2.07e-06	0.000533	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—ESR1—osteoporosis	2e-06	0.000515	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—ESR1—osteoporosis	2e-06	0.000514	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—ESR1—osteoporosis	1.98e-06	0.000509	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—IL6—osteoporosis	1.88e-06	0.000484	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—IRS1—osteoporosis	1.87e-06	0.000481	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—IRS1—osteoporosis	1.87e-06	0.00048	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—IRS1—osteoporosis	1.85e-06	0.000475	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—POMC—osteoporosis	1.8e-06	0.000464	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—POMC—osteoporosis	1.8e-06	0.000462	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—POMC—osteoporosis	1.78e-06	0.000458	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—IL6R—osteoporosis	1.76e-06	0.000452	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—IL6R—osteoporosis	1.75e-06	0.000451	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—IL6R—osteoporosis	1.74e-06	0.000446	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—IGF1—osteoporosis	1.73e-06	0.000446	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—IGF1—osteoporosis	1.73e-06	0.000444	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—IGF1—osteoporosis	1.71e-06	0.00044	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—MYC—osteoporosis	1.48e-06	0.000381	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—TGFB1—osteoporosis	1.48e-06	0.00038	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—IL6—osteoporosis	1.33e-06	0.000341	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—IL6—osteoporosis	1.32e-06	0.00034	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—IL6—osteoporosis	1.31e-06	0.000337	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—IL6—osteoporosis	1.11e-06	0.000286	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—MYC—osteoporosis	1.04e-06	0.000268	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—TGFB1—osteoporosis	1.04e-06	0.000267	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—MYC—osteoporosis	1.04e-06	0.000267	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—TGFB1—osteoporosis	1.04e-06	0.000266	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—MYC—osteoporosis	1.03e-06	0.000265	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—TGFB1—osteoporosis	1.03e-06	0.000264	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—IL6—osteoporosis	7.83e-07	0.000201	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—IL6—osteoporosis	7.81e-07	0.000201	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—IL6—osteoporosis	7.73e-07	0.000199	CbGpPWpGaD
